Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
PPM1D
Mutations in Patients with Clonal Haematopoiesis and Clonal Cytopenias
2
Mins
July 2025
TP53 and PPM1D are key regulators of DNA damage response and repair, and somatic mutations in these genes often…
Read more
2
Mins
24 Jul 2025
PPM1D
Mutations in Patients with Clonal Haematopoiesis and Clonal Cytopenias
TP53 and PPM1D are key regulators of DNA damage response and repair, and somatic mutations in these genes often…
1
Mins
24 Jul 2025
Hydroxyurea and Gut Function in Sickle Cell Disease Mice
Sickle cell disease (SCD) is a genetic disorder characterised by chronic inflammation, vaso-occlusion, and endothelial…
1
Mins
24 Jul 2025
Long-Term Outcomes After Allo-HSCT in ALL
Patients (pts) with acute lymphoblastic leukaemia (ALL) in difficult first complete remission (CR) or in second CR, and…
1
Mins
24 Jul 2025
Microfluidic Testing in Patients with BDUC
In 40–70% of patients referred to a haematologist for the evaluation of an increased bleeding tendency, no diagnosis can…
2
Mins
24 Jul 2025
Lenzilumab and Azacitidine Combination Therapy in Proliferative CMML
Chronic myelomonocytic leukaemia (CMML) is a rare cancer orchestrated by granulocyte-macrophage colony-stimulating factor (GM-CSF)…
2
Mins
25 Jul 2024
TET2
Mutations Affect Stem Cell Response to Immune Stress
Understanding how loss of function mutation of TET2 in haematopoietic stem cells (HSC) changes their response to stress is crucial to…
2
Mins
25 Jul 2024
KMT2A-MLLT3
-Induced Leukaemia Changes During Ontogenic Stages
The KMT2A-MLLT3 (also known as MLL-AF9) fusion is associated with acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), and mixed…
2
Mins
25 Jul 2024
A-HIPI Prognostic Index in Turkish Patients with Hodgkin Lymphoma: Single-Center Retrospective Study
The historical International Prognostic Score (IPS-7), which was developed with patient data from the 1980s, and the more recent IPS-3…
Loading posts...
1
2
3
…
8
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View